Literature DB >> 23374769

Validation of Randall's plaque theory using unenhanced abdominal computed tomography.

Alexandru Ciudin1, Maria Pilar Luque Galvez, Rafael Salvador Izquierdo, Mihai Gabriel Diaconu, Agustin Franco de Castro, Vlad Constantin, Jose Ricardo Alvarez-Vijande, Carlos Nicolau, Antonio Alcaraz Asensio.   

Abstract

OBJECTIVE: To determine whether nephrolithiasis is associated with radiographic changes in renal papillae.
MATERIALS AND METHODS: We performed a prospective study comparing papillae attenuation in a stone-forming group (SFG) and a healthy stone-free control group (CG). The SFG inclusion criteria were active stone disease diagnosed by abdominal computed tomography and stone analysis showing calcium composition. For the CG, we included living kidney donors without stone disease. Papillae tip attenuation was measured using nonenhanced computed tomography scans in Hounsfield units (HUs) for an area with a mean size of 0.1 cm(2). The mean density of the 3 caliceal groups was calculated for each kidney. Student's t test was used for statistical analysis, and the receiver operating characteristic curve was used to determine a threshold separating the CG and SFG.
RESULTS: A total of 134 SFG and 134 CG patients met the inclusion criteria. The SFG and CG had similar demographic characteristics. Unilateral lithiasis was encountered in 92 patients (68.6%). The mean HU density of the papillae of the affected side in the SFG was significantly greater than in the CG (43.9 HU vs 33.9 HU, P = .001). No significant difference was seen between the affected and unaffected side in the SFG (43.9 HU vs 42.9 HU, P = .56). The receiver operating characteristic analysis showed an area under the curve of 0.91, with an optimal threshold at 40 HU and a specificity of 92% and a sensitivity of 91%.
CONCLUSION: The density of the renal papilla significantly increased in the SFG in both the affected and the nonaffected kidneys compared with the CG. These findings suggest the presence of calcium deposits in the papillae, validating Randall's theory.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23374769     DOI: 10.1016/j.urology.2012.10.010

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Kidney stones and imaging: what can your radiologist do for you?

Authors:  Raphaële Renard-Penna; Aurélie Martin; Pierre Conort; Pierre Mozer; Philippe Grenier
Journal:  World J Urol       Date:  2014-10-26       Impact factor: 4.226

Review 2.  Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

3.  Papillary calcifications: a new prognostic factor in idiopathic calcium oxalate urolithiasis.

Authors:  Walter Ludwig Strohmaier; Markus Hörmann; Gernot Schubert
Journal:  Urolithiasis       Date:  2013-10-08       Impact factor: 3.436

4.  Increased renal papillary density in kidney stone formers detectable by CT scan is a potential marker of stone risk, but is unrelated to underlying hypercalciuria.

Authors:  Linda Shavit; Daniela Girfoglio; Alex Kirkham; Darrell Allen; Pietro Manuel Ferraro; Shabbir Moochhala; Robert Unwin
Journal:  Urolithiasis       Date:  2016-03-29       Impact factor: 3.436

5.  Comparison of Turkish Primary, Recurrent, and Non Stone-Forming Patients Using Hounsfield Unit Measurements: How Useful Is It?

Authors:  Ersan Arda; Basri Cakıroglu; Esra Akdeniz; Ilkan Yuksel; Gizem Cetin; Suleyman Hilmi Aksoy
Journal:  Curr Urol       Date:  2019-05-10

6.  Reproducibility of a novel computed-tomography based measurement of renal papillary density in the Framingham Heart Study.

Authors:  Aaron J Yeoh; Joe Massaro; Caroline S Fox; Udo Hoffmann; Brian H Eisner; Gearoid M McMahon
Journal:  BMC Res Notes       Date:  2015-12-22

7.  Changes in renal papillary density after hydration therapy in calcium stone formers.

Authors:  Pietro Manuel Ferraro; Matteo Vittori; Giuseppe Macis; Alessandro D'Addessi; Gianmarco Lombardi; Claudia Palmisano; Jacopo Gervasoni; Aniello Primiano; Pier Francesco Bassi; Giovanni Gambaro
Journal:  BMC Urol       Date:  2018-11-12       Impact factor: 2.264

8.  Usefulness of measuring renal papillae in Hounsfield units in stone - forming patients.

Authors:  Miguel Angel Arrabal-Polo; Maria Del Carmen Cano-Garcia; Juan Esteban Huerta-Brunel; Guillermo Hidalgo-Agullo; Luis Roletto-Salmo; Miguel Arrabal-Martín
Journal:  Int Braz J Urol       Date:  2016-09-01       Impact factor: 1.541

Review 9.  Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.

Authors:  Giovanni Gambaro; Emanuele Croppi; Fredric Coe; James Lingeman; Orson Moe; Elen Worcester; Noor Buchholz; David Bushinsky; Gary C Curhan; Pietro Manuel Ferraro; Daniel Fuster; David S Goldfarb; Ita Pfeferman Heilberg; Bernard Hess; John Lieske; Martino Marangella; Dawn Milliner; Glen M Preminger; Jose' Manuel Reis Santos; Khashayar Sakhaee; Kemal Sarica; Roswitha Siener; Pasquale Strazzullo; James C Williams
Journal:  J Nephrol       Date:  2016-07-25       Impact factor: 3.902

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.